Contact Congress about H.R. 6610: Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]

PBMs in federal employee health plans would have to pay pharmacies more predictable minimum rates. Drug rebates would have to lower some patients' costs at the counter. PBMs that keep breaking the rules could face fines or get banned from the program.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] is a House bill in committee. The latest recorded action: Referred to the House Committee on Oversight and Government Reform.

Latest action on H.R. 6610: Referred to the House Committee on Oversight and Government Reform.

Who this affects: This bill mainly affects people in federal employee health plans, the pharmacies that fill their prescriptions, the PBMs that run drug benefits, and the insurance carriers that hire those PBMs. The biggest direct effects are on pharmacy payments, what some patients pay at checkout, and the compliance and penalty risks for PBMs and carriers.

Why this matters: This bill matters because it could change both what pharmacies get paid and what some patients pay when they pick up medicine. It tries to stop practices that lawmakers believe squeeze pharmacies or steer patients to PBM-linked stores. It also gives OPM more tools to police the companies running drug benefits in federal employee plans. The full effect on premiums or total government spending is still unclear from the bill text.

Key provisions in H.R. 6610

• PBMs would have to pay in-network pharmacies a set minimum amount for covered drugs. That amount is the national average drug acquisition cost, or wholesale acquisition cost if no average exists, plus either 4% or $50, whichever is lower.
• PBMs would also have to pay pharmacies a dispensing fee for filling the prescription. The fee must match the Medicaid dispensing fee in the state where the pharmacy is located.
• Drug maker rebates would have to lower what the patient pays at the counter. The copay or coinsurance must be based on the drug's net price after the rebate is counted.
• After the patient's share is reduced, the PBM would have to pass the rest of the rebate to the health plan carrier. The PBM could not keep that leftover amount.
• PBMs could not push patients toward certain pharmacies, including pharmacies they own or control. They also could not advertise or promote one in-network pharmacy over another.

How Modern Action helps you take action on H.R. 6610

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 6610

What is H.R. 6610?

PBMs in federal employee health plans would have to pay pharmacies more predictable minimum rates. Drug rebates would have to lower some patients' costs at the counter. PBMs that keep breaking the rules could face fines or get banned from the program.

How do I support or oppose H.R. 6610?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about H.R. 6610?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain H.R. 6610 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.